Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Risk prediction model does not accurately identify lung cancer risks in diverse population

Lung cancer is the third most common cancer in the U.S. and the leading cause of cancer death, with about 80% of the total 154,000 deaths recorded each year caused by cigarette smoking. Black men are more likely to develop and die from lung cancer than persons of any other racial or ethnic group, pointing to severe racial disparities.

5 May 2021

New drug class effective in treating certain types of ovarian cancers

A study published today in Nature Communications shows that the drug rucaparib has been effective in treating certain types of ovarian cancers if used early in treatment, after a diagnosis, and before the cancer cells build up a resistance to chemotherapy.

4 May 2021

Rucaparib drug is effective in treating certain types of ovarian cancers, shows study

4 May 2021

Drug synthesized from Kentucky-grown plant shows promise in treating ovarian cancer

A new study from University of Kentucky Markey Cancer researchers shows that Artemisia annua, a plant that has been traditionally used for its anti-malaria components, shows promise in treating ovarian cancer.

26 Apr 2021

1 in 6 patients with colorectal cancer found to have inherited genetic mutations

A new Mayo Clinic study bolsters evidence that colorectal cancer is often imprinted in family genes and passed on from one generation to the next.

20 Apr 2021

Modified immune cells may prove a game-changer for patients with late-stage cancers

Modified immune cells that ruthlessly kill cancerous tumors may prove a game-changer for people living with late-stage cancer.

15 Apr 2021

Study reveals new insights into the effects of chemotherapy on tumor microenvironment

Research from Queen Mary University of London has revealed novel insights into the effects of chemotherapy on the tumor microenvironment (TME).

12 Apr 2021

Stress incontinence surgery does not increased risk of pelvic cancers

Women undergoing surgery to treat stress urinary incontinence (SUI) are not at increased risk of developing pelvic cancers, according to a large-scale, population-based study in The Journal of Urology, Official Journal of the American Urological Association.

8 Apr 2021

Advancing the Diagnosis and Treatment of Ovarian Cancer

In this interview, News-Medical talks to Dr. Marcos Quintela Vasquez about the work he is conducting regarding the diagnosis and treatment of ovarian cancer in partnership with Porvair Sciences.

From Porvair Sciences Limited 7 Apr 2021

New research could rescue failed immunotherapies for treating solid tumors

New research from the UVA Cancer Center could rescue once-promising immunotherapies for treating solid cancer tumors, such as ovarian, colon and triple-negative breast cancer, that ultimately failed in human clinical trials.

7 Apr 2021

Researchers define genetic landscape of uterine leiomyosarcomas

In a new study, Yale Cancer Center researchers have defined the genetic landscape of uterine leiomyosarcomas (uLMS).

6 Apr 2021

Despite guidelines, end-of-life care remains aggressive for ovarian cancer patients

People with ovarian cancer frequently receive aggressive end-of-life care despite industry guidelines that emphasize quality of life for those with advanced disease, according to a recent study.

6 Apr 2021

Study explores how CAR T immunotherapy could be used to treat solid tumors

A study recently published in the journal Science looked into how CAR T immunotherapy could be used to treat solid tumors in addition to leukemias. The programming of CAR T cells opens avenues for applying cell therapies to, for example, breast cancer or ovarian cancer in the future.

18 Mar 2021

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

KIYATEC, Inc researchers demonstrated that their immune-modified ex vivo platform can measure treatment response through direct interaction between a patient's cancer and infiltrating immune cells, and immuno-oncology agents.

12 Mar 2021

Evolutionary forces account for gender imbalance in the occurrence of autism, other health conditions

Evolutionary forces drive a glaring gender imbalance in the occurrence of many health conditions, including autism, a team of genetics researchers has concluded.

4 Mar 2021

Scientists receive grant to investigate tumor development within a natural environment

Unlike many of us during the COVID-19 pandemic, biological cells are not isolated from the outside world. Chemical variations, intercellular activity, and other microenvironmental factors impact cell survival.

25 Feb 2021

Researchers use functional test to measure the effect of inherited variants in BRCA2 cancer gene

Researchers at Mayo Clinic have combined results from a functional test measuring the effect of inherited variants in the BRCA2 breast and ovarian cancer gene with clinical information from women who received genetic testing to determine the clinical importance of many BRCA2 variants of uncertain significance (VUS).

20 Feb 2021

New proton therapy targets treatment-resistant cancer cells

Mayo Clinic researchers have developed a novel proton therapy technique to more specifically target cancer cells that resist other forms of treatment.

18 Feb 2021

Researchers discover previously-unknown function in enzyme critical for cancer growth

Considered the most lethal form of DNA damage, double-strand breaks must be repaired to prevent cell death. In developing therapies for hard-to-treat breast and ovarian cancers in patients with BRCA gene mutations, scientists aim to identify ways to keep cancer cells from using DNA break repair pathways.

11 Feb 2021

Study finds way to detect ovarian cancer in patients using Pap test samples

A study led by researchers at the University of Minnesota Medical School found a way to detect the presence of ovarian cancer in patients using Pap test samples, normally used to detect cervical cancer.

9 Feb 2021

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Risk prediction model does not accurately identify lung cancer risks in diverse population

New drug class effective in treating certain types of ovarian cancers

Rucaparib drug is effective in treating certain types of ovarian cancers, shows study

Drug synthesized from Kentucky-grown plant shows promise in treating ovarian cancer

1 in 6 patients with colorectal cancer found to have inherited genetic mutations

Modified immune cells may prove a game-changer for patients with late-stage cancers

Study reveals new insights into the effects of chemotherapy on tumor microenvironment

Stress incontinence surgery does not increased risk of pelvic cancers

Advancing the Diagnosis and Treatment of Ovarian Cancer

New research could rescue failed immunotherapies for treating solid tumors

Researchers define genetic landscape of uterine leiomyosarcomas

Despite guidelines, end-of-life care remains aggressive for ovarian cancer patients

Study explores how CAR T immunotherapy could be used to treat solid tumors

Immune-modified ex vivo platform can measure treatment response of ovarian cancer

Evolutionary forces account for gender imbalance in the occurrence of autism, other health conditions

Scientists receive grant to investigate tumor development within a natural environment

Researchers use functional test to measure the effect of inherited variants in BRCA2 cancer gene

New proton therapy targets treatment-resistant cancer cells

Researchers discover previously-unknown function in enzyme critical for cancer growth

Study finds way to detect ovarian cancer in patients using Pap test samples

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in